Regression of Diabetic Macular Edema by Remission of Type 2 Diabetes with Plant-Based Diet: A Case Report and Review

The current practice in the management DR has been primarily aimed at its neovascular complications, and rests upon the use of laser photocoagulation, intravitreal anti-VGEF injections, and on occasion glucocorticoid therapy. However, these treatments are not curative and there is increasing evidence that anti-VEGF treatment is unlikely to improve retinal perfusion and may not prevent gradual progression of nonperfusion or loss of peripheral visual field associated with worsening diabetes-related eye disease [7]. Moreover, there are many short term and long-term complications associated with these treatments. Diabetic retinopathy is the result of the convergence of many metabolic abnormalities leading to retinal vasculature dysfunction, inflammation, and neurodegeneration [8]. DR has been considered a microcirculatory disease of the retina. However, there is emerging evidence to suggest that retinal neurodegeneration is an early event in the pathogenesis of DR [9]. Introduction